Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.

Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.

Apheresis with the Prosorba column is safe and effective for treating refractory rheumatoid arthritis. It also is resource intensive. Economic evaluation of Prosorba column therapy could help promote efficient use of this technology. This article describes a framework and the data requirements for a...

Полное описание

Библиографические подробности
Главные авторы:	Griffiths, R, Slurzberg, J
Формат:	Journal article
Язык:	English
Опубликовано:	2001

Схожие документы

Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.
по: Griffiths, R, и др.
Опубликовано: (2000)

Pathogenesis and therapy of rheumatoid arthritis.
по: Williams, R
Опубликовано: (2006)

Cytokine therapy in rheumatoid arthritis.
по: Maini, R, и др.
Опубликовано: (1996)

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
по: Vladimira V. Boyadzieva, и др.
Опубликовано: (2018-07-01)

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
по: Krzysztof Kowalik, и др.
Опубликовано: (2018-12-01)

Indirect costs of the Rheumatoid arthritis in Poland
по: Emilia Howoruszko, и др.
Опубликовано: (2019-05-01)

Indirect costs of the Rheumatoid arthritis in Poland
по: Emilia Howoruszko, и др.
Опубликовано: (2019-05-01)

Cost-utility analysis of abatacept in rheumatoid arthritis in Italy
по: Simona de Portu, и др.
Опубликовано: (2008-03-01)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
по: Cynthia Said, и др.
Опубликовано: (2013-01-01)

Effectiveness and costs of multidisciplinary care in patients with rheumatoid arthritis
по: S.M.M. Verstappen
Опубликовано: (2003-08-01)

Gene therapy for rheumatoid arthritis?
по: Feldmann, M
Опубликовано: (2001)

Antibody therapy for rheumatoid arthritis.
по: Taylor, P
Опубликовано: (2003)

Adjunctive Therapies in Rheumatoid Arthritis
по: Tonatiuh González Heredia, и др.
Опубликовано: (2024-11-01)

Infliximab in the therapy of rheumatoid arthritis
по: G. V. Lukina, и др.
Опубликовано: (2016-05-01)

BIOBEHAVIORAL THERAPY OF RHEUMATOID ARTHRITIS
по: N. A. Shabanova, и др.
Опубликовано: (2013-04-01)

Biologic therapy of rheumatoid arthritis
по: Damjanov Nemanja, и др.
Опубликовано: (2009-01-01)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
по: Feldmann, M, и др.
Опубликовано: (2011)

Anti-cytokine therapy for rheumatoid arthritis.
по: Maini, R, и др.
Опубликовано: (2000)

The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.
по: Jaana T Joensuu, и др.
Опубликовано: (2015-01-01)

Female patients with rheumatoid arthritis – hospitalisation costs
по: Luana Andreea Macovei, и др.
Опубликовано: (2019-12-01)

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis
по: Alison Hammond, и др.
Опубликовано: (2021-01-01)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
по: Isaacs, J, и др.
Опубликовано: (1992)

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
по: R. Ariza, и др.
Опубликовано: (2014-07-01)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
по: Isaacs, J, и др.
Опубликовано: (1992)

Leflunomide and rheumatoid arthritis: a systematic review of effectiveness, safety and cost implications
по: Hewitson, P, и др.
Опубликовано: (2001)

The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
по: Allan Wailoo, и др.
Опубликовано: (2017-11-01)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis.
по: Williams, R
Опубликовано: (2013)

Fibrinolytic activity in rheumatoid arthritis and the effects of prednisolone therapy
по: Gough, S, и др.
Опубликовано: (1993)

EFFECT OF INTRAMUSCULAR GOLD THERAPY ON THE COURSE OF RHEUMATOID ARTHRITIS
по: Soroush, и др.
Опубликовано: (1996-06-01)

EFFECT OF INTRAMUSCULAR GOLD THERAPY ON THE COURSE OF RHEUMATOID ARTHRITIS
по: Soroush, и др.
Опубликовано: (1996-06-01)

Certolizumab pegol in therapy for rheumatoid arthritis
по: Galina Viktorovna Lukina, и др.
Опубликовано: (2012-06-01)

Part II. Therapy for rheumatoid arthritis
по: Natalia Viktorovna Demidova
Опубликовано: (2013-12-01)

EFFICIENCY OF PHOTOMAGNETIC THERAPY IN RHEUMATOID ARTHRITIS
по: Voichenko N. V., и др.
Опубликовано: (2020-06-01)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
по: Maini, R, и др.
Опубликовано: (1994)

Markov's model of decision making on basic therapy of rheumatoid arthritis: monotherapy and its cost
по: D V Goryachev, и др.
Опубликовано: (2004-05-01)

Associations of Cost Sharing With Rheumatoid Arthritis Disease Burden
по: Sharon Dowell, и др.
Опубликовано: (2023-08-01)

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
по: Martin J. Bergman, и др.
Опубликовано: (2020-08-01)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
по: Findeisen KE, и др.
Опубликовано: (2021-08-01)

Epidemiology, resource use and costs of rheumatoid arthritis in Argentina
по: Anastasia Secco, и др.
Опубликовано: (2020-09-01)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
по: Victoria Furer, и др.
Опубликовано: (2023-04-01)